IL-10 is an effector molecule mediating urocanic acid-induced immunosuppression

Author： Krulova M.   Kuffova L.   Zajcova A.   Filipec M.   Holan V.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.31, Iss.1, 1999-02, pp. : 1218-1219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measles Virus Induced Immunosuppression: Targets and Effector Mechanisms

By  

Current Molecular Medicine, Vol. 1, Iss. 2, 2001-05 ,pp. : 163-181

Bentham Science Publishers

Access to resources Recommend Favorite

Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32)

By Woo J.   Iyer S.   Cornejo M.-C.   Mori N.   Gao L.   Sipos I.   Maines M.   Buelow R.  

Transplant Immunology, Vol. 6, Iss. 2, 1998-06 ,pp. : 84-93

Elsevier

Access to resources Recommend Favorite

Administration of Human Umbilical Cord Blood Cells Produces Interleukin-10 (IL-10) in IL-10 Deficient Mice Without Immunosuppression

By  

Current Stem Cell Research & Therapy, Vol. 5, Iss. 1, 2010-03 ,pp. : 13-16

Bentham Science Publishers

Access to resources Recommend Favorite

Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation

By Lee Jee-Boong   Lee Kyoo-A   Chang Jun  

International Immunology, Vol. 19, Iss. 9, 2007-09 ,pp. : 1039-1048

Oxford University Press

Access to resources Recommend Favorite

The IL2 pathway in clinical immunosuppression

By Nashan B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3072-3074

Elsevier

Access to resources Recommend Favorite